SCEDULE 13G

Company

AIM ImmunoTech Inc.

Filed

February 14, 2001

Accession Number

0000891092-01-000240

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →